Sandrine Piret-Gerard, Chief Commercialization Officer (CCO) at argenx, shared on LinkedIn:
“Leaving Las Vegas energized by the conversations, connections and perspectives at HLTHUSA.
One thought is clear: scientific innovation only matters if it reaches the patients who need it.
We cannot build for patients without building with them. Co-creating with patients and understanding their lived experiences helps us better address their needs, challenges and expectations.
At argenx, this is at the heart of how we work: co-creating entrepreneurial science by bringing together scientific innovation, clinical insights and patient experiences to develop better treatments and better ways to deliver them.
Thank you HLTH Inc. for the opportunity to exchange perspectives alongside Dr. Purvi Parikh, Andrea Daniels and Megan Antonelli.
Conversations like these remind us who we ultimately innovate for – and why we must innovate with them.”
Other articles about Sandrine Piret-Gerard on OncoDaily.